» Articles » PMID: 32547085

CircHIPK3 Facilitates the G2/M Transition in Prostate Cancer Cells by Sponging MiR-338-3p

Overview
Publisher Dove Medical Press
Specialty Oncology
Date 2020 Jun 18
PMID 32547085
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Circular RNAs (circRNAs) play a crucial role in gene expression regulation. CircHIPK3 is a circRNA derived from Exon 2 of HIPK3 gene and its role in prostate cancer (PCa) is still unclear.

Methods: CCK8 assays, flow cytometry and colony formation assays were performed to assess the effects of circHIPK3 in PCa cells. Bioinformatics analysis, RNA pull-down assay, RNA immunoprecipitation assay (RIP), and luciferase activity assay were performed to dissect the mechanism underlying circHIPK3-mediated G2/M transition in PCa cells.

Results: CircHIPK3 expression was upregulated in PCa cells and prostate cancer tissues. Overexpression of circHIPK3 or circHIPK3 silencing altered PCa viability, proliferation and apoptosis in vitro. CircHIPK3 could sponge miR-338-3p and inhibit its activity, resulting in increased expression of Cdc25B and Cdc2 in vitro.

Conclusion: CircHIPK3 promotes G2/M transition and induces PCa cell proliferation by sponging miR-338-3p and increasing the expression of Cdc25B and Cdc2. CircHIPK3 may play an oncogenic role in PCa.

Citing Articles

The dual role of circHIPK3 in cancer and its implications for multiple drugs resistance: a systematic review and computational approach.

Campelo M, Reis-das-Merces L, Vidal A, da Silva F, de Oliveira A, Monteiro J Front Oncol. 2025; 15:1547889.

PMID: 40061896 PMC: 11885226. DOI: 10.3389/fonc.2025.1547889.


Phytochemical synergies in BK002: advanced molecular docking insights for targeted prostate cancer therapy.

Park M, Choi J, Maharub Hossain Fahim M, Asevedo E, Nurkolis F, Ribeiro R Front Pharmacol. 2025; 16:1504618.

PMID: 40034825 PMC: 11872924. DOI: 10.3389/fphar.2025.1504618.


Multiple roles of circular RNAs in prostate cancer: from the biological basis to potential clinical applications.

Zheng X, Song L, Cao C, Sun S Eur J Med Res. 2025; 30(1):140.

PMID: 40016786 PMC: 11866600. DOI: 10.1186/s40001-025-02382-0.


Circ_0001047 inhibits prostate cancer progression and enhances abiraterone sensitivity via miR-122-5p/FKBP5/PHLPP1/AKT axis in vitro.

Chen Z, Fu S, Shan Y, He Z, Gu J, Wu H Discov Oncol. 2024; 15(1):569.

PMID: 39419900 PMC: 11486870. DOI: 10.1007/s12672-024-01408-z.


Imaging and quantification of human and viral circular RNAs.

Jaijyan D, Yang S, Ramasamy S, Gu A, Zeng M, Subbian S Nucleic Acids Res. 2024; 52(15):e70.

PMID: 39051561 PMC: 11347131. DOI: 10.1093/nar/gkae583.


References
1.
Ngan E, Hashimoto Y, Ma Z, Tsai M, Tsai S . Overexpression of Cdc25B, an androgen receptor coactivator, in prostate cancer. Oncogene. 2003; 22(5):734-9. DOI: 10.1038/sj.onc.1206121. View

2.
Chen L . The biogenesis and emerging roles of circular RNAs. Nat Rev Mol Cell Biol. 2016; 17(4):205-11. DOI: 10.1038/nrm.2015.32. View

3.
Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

4.
Wang Y, Qin H . miR-338-3p targets and suppresses tumorigenicity of prostate cancer cells. Am J Cancer Res. 2019; 8(12):2564-2574. PMC: 6325485. View

5.
Sur S, Agrawal D . Phosphatases and kinases regulating CDC25 activity in the cell cycle: clinical implications of CDC25 overexpression and potential treatment strategies. Mol Cell Biochem. 2016; 416(1-2):33-46. PMC: 4862931. DOI: 10.1007/s11010-016-2693-2. View